Main Sequence Ventures
Elaine Stead is a seasoned professional in venture capital and entrepreneurship with extensive experience in managing investment funds and advising institutions on scaling technology-led ventures. Currently serving as Principal at Main Sequence since March 2024, Elaine previously held the role of Managing Director at Human Venture Capital, where responsibilities included managing the South Australian Venture Capital Fund. Elaine's expertise also extends to the Australian National University, where as Director of New Ventures and Entrepreneurship, leadership focused on startup investment strategies. As a Co-Founder and Chief Investment Officer at Tribe Global Ventures, Elaine facilitated investments in Australian and New Zealand B2B companies aimed at expanding into international markets. Additional roles include strategic advisory at Deloitte and board memberships at organizations such as StartupAUS and Fivecast. Elaine possesses a Doctor of Philosophy in Biochemistry and has been recognized as a member of the Australian Institute of Company Directors.
This person is not in the org chart
Main Sequence Ventures
2 followers
We are Australia’s deep tech investment fund tackling the world’s biggest challenges by turning today’s scientific discoveries into tomorrow’s industries. Main Sequence works closely with scientists, researchers and industry collaborators to create, fund and accelerate new companies and industries that accelerate humanity for a more prosperous future. Main Sequence was set up in 2017 to manage the CSIRO Innovation Fund, founded by the Australian Government and the national science agency to reinvest its historic contributions into the successes of the future. Over the past four years, Main Sequence has invested in 39 companies changing the way healthcare is delivered, food is produced, spaces are connected and more. These investments have led to more than 60 company collaborative projects with universities and 19 projects with CSIRO.